Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. INNV
INNV logo

INNV Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
7.990
Open
7.810
VWAP
7.90
Vol
114.15K
Mkt Cap
1.07B
Low
7.810
Amount
901.19K
EV/EBITDA(TTM)
18.23
Total Shares
135.70M
EV
1.05B
EV/OCF(TTM)
17.79
P/S(TTM)
1.17
InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.
Show More

Events Timeline

(ET)
2026-02-05
08:50:00
InnovAge Meets Colorado Lawmakers to Emphasize Importance of Senior Care
select
2026-02-03 (ET)
2026-02-03
16:50:00
Company Raises EBITDA Guidance to $70M-$75M
select
2026-02-03
16:50:00
InnovAge Reports Q2 Revenue of $239.7M
select
2026-01-29 (ET)
2026-01-29
08:10:00
InnovAge Appoints New Board Members, Expands to 11 Directors
select
2025-12-16 (ET)
2025-12-16
08:10:00
INNOVATE Announces MediBeacon FDA Approval for Next-Gen TGFRTM System
select
2025-11-03 (ET)
2025-11-03
17:03:24
InnovAge names Paul Taheri as its new chief medical officer.
select
2025-09-23 (ET)
2025-09-23
08:15:14
InnovAge Names Delk as Executive Vice President and Chief Administrative Officer
select
2025-09-09 (ET)
2025-09-09
16:31:47
InnovAge projects FY26 revenue between $900M and $950M, with consensus at $938.25M
select

News

Benzinga
9.5
02-04Benzinga
Cirrus Logic Reports Strong Q3 Earnings, Shares Surge
  • Earnings Beat: Cirrus Logic reported third-quarter earnings of $2.97 per share, surpassing the analyst consensus estimate of $2.44 per share, indicating a significant improvement in profitability and boosting investor confidence.
  • Sales Growth: The company achieved quarterly sales of $580.620 million, exceeding the analyst consensus estimate of $533.890 million, demonstrating strong market demand and driving sustained performance growth.
  • Stock Surge: Following the positive earnings report, Cirrus Logic's shares jumped 7.6% to $134.10 on Wednesday, reflecting market optimism regarding the company's future growth potential.
  • Optimistic Guidance: Cirrus Logic provided fourth-quarter sales guidance that is expected to exceed market estimates, further solidifying its competitive position in the semiconductor industry.
seekingalpha
9.5
02-04seekingalpha
InnovAge Reports Strong Q2 2026 Earnings with Raised Guidance
  • Strong Financial Performance: InnovAge reported total revenues of $239.7 million for Q2, reflecting a 14.7% year-over-year increase, with a center-level contribution margin of $52.8 million and adjusted EBITDA of $22.2 million, achieving a 9.2% EBITDA margin for the first time, indicating sustained operational and financial execution improvements.
  • Improved Medicaid Environment: The company made progress in Medicaid eligibility and redeterminations, enhancing timeliness and accuracy, reducing reserves, and reinstating coverage for several participants, which is expected to further enhance participant experience and revenue.
  • Raised Full-Year Guidance: InnovAge raised its fiscal 2026 full-year guidance, now expecting member months between 92,900 and 95,700, total revenue between $925 million and $950 million, and adjusted EBITDA between $70 million and $75 million, reflecting ongoing operational improvements and better-than-expected Medicaid rates.
  • Governance Changes: Tom Scully returned as Chairman of the Board, with two board members rejoining, and management expressed gratitude for former leader Jim Carlson's contributions, demonstrating stability in governance and confidence in future growth.
seekingalpha
9.5
02-03seekingalpha
InnovAge Q2 Earnings Beat Expectations with Raised FY2026 Guidance
  • Strong Earnings Report: InnovAge reported a GAAP EPS of $0.08 for Q2, beating expectations by $0.04, indicating sustained improvement in profitability that is likely to positively impact stock performance.
  • Significant Revenue Growth: The company achieved revenues of $239.71 million, a 14.7% year-over-year increase, surpassing market expectations by $11.41 million, reflecting strong business expansion and market demand.
  • Raised Financial Guidance: InnovAge has raised its full fiscal year 2026 financial guidance, projecting total revenues between $925 million and $950 million, with adjusted EBITDA expected to be between $70 million and $75 million, demonstrating confidence in future growth.
  • Stable Membership Growth: While the ending census forecast remains unchanged, total member months are expected to reach between 92,900 and 95,700, indicating stable growth in the customer base and enhancing market competitiveness.
Newsfilter
1.0
2025-12-30Newsfilter
InnovAge CEO Patrick Blair to Present at 2026 J.P. Morgan Healthcare Conference
  • Executive Presentation: InnovAge CEO Patrick Blair is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, showcasing the company's leadership in providing comprehensive healthcare services to frail seniors, which is expected to attract investor interest.
  • Market Leadership: As of September 30, 2025, InnovAge serves approximately 7,890 participants across 20 centers in six states, indicating its significant impact in managing high-cost healthcare, thereby further solidifying its market position.
  • Innovative Care Model: InnovAge's PACE model aims to enhance the ability of seniors to live independently while reducing over-utilization of high-cost care settings, reflecting the company's commitment to improving care quality for older adults, which may attract more support from government payors.
  • Investor Relations: The live webcast of the conference will provide real-time information to investors, enhancing interaction between the company and its investors, thereby increasing transparency and trust in the healthcare sector.
Globenewswire
7.0
2025-12-11Globenewswire
InnovAge Settles $27 Million Securities Fraud Class Action with Investors
  • Settlement Amount Finalized: InnovAge Holding Corp. has reached a $27 million cash settlement with investors to resolve allegations of securities fraud related to its IPO materials, indicating a significant financial burden on the company due to legal issues.
  • Litigation Background: The case, filed in 2021, accused InnovAge of providing false information to investors during the IPO period, leading to investor losses and reflecting serious deficiencies in corporate governance and transparency.
  • Significant Stock Impact: Following the announcement of regulatory sanctions, InnovAge's stock plummeted by 78%, making it one of the five worst-performing IPOs of 2021, highlighting a severe lack of market confidence in the company's operations and compliance.
  • Legal Team Recognition: The Honorable William J. Martinez of the U.S. District Court commended the plaintiffs' counsel for their exceptional performance, underscoring the importance of legal expertise and strategy in complex securities litigation.
Newsfilter
8.0
2025-09-11Newsfilter
InnovAge Recognized as a Top Workplace in Aging Services™ by Fortune® and Great Place to Work®
  • InnovAge Recognition: InnovAge has been named one of the top 15 organizations in the aging services category by Fortune's Best Workplaces in Aging Services for 2025, highlighting its supportive workplace culture and commitment to high-quality care for older adults.

  • Employee Commitment: CEO Patrick Blair emphasized that the recognition reflects the dedication of InnovAge's over 2,400 employees, who are committed to providing compassionate care and fostering a positive work environment, further validated by InnovAge's sixth consecutive honor as a Great Place to Work®.

Valuation Metrics

The current forward P/E ratio for InnovAge Holding Corp (INNV.O) is 21.18, compared to its 5-year average forward P/E of -54.12. For a more detailed relative valuation and DCF analysis to assess InnovAge Holding Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-54.12
Current PE
21.18
Overvalued PE
1080.72
Undervalued PE
-1188.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-4.46
Current EV/EBITDA
11.08
Overvalued EV/EBITDA
190.11
Undervalued EV/EBITDA
-199.03

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.26
Current PS
0.74
Overvalued PS
2.22
Undervalued PS
0.29

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

طيب ابي الاسهم الي زاد الحجم فيها خلال اخر5 ايام بشكل غريب
Intellectia · 1733 candidates
Week Price Change Pct: >= $0.00Weekly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ELPW logo
ELPW
eLong Power Holding Ltd
4.46M
LIMN logo
LIMN
Liminatus Pharma Inc
19.36M
AZN logo
AZN
AstraZeneca PLC
288.71B
POAS logo
POAS
Phaos Technology Holdings (Cayman) Limited
110.72M
CGTL logo
CGTL
Creative Global Technology Holdings Ltd
143.03M
ANL logo
ANL
Adlai Nortye Ltd
415.68M

Whales Holding INNV

C
Coliseum Capital Management, LLC
Holding
INNV
-15.45%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is InnovAge Holding Corp (INNV) stock price today?

The current price of INNV is 7.885 USD — it has decreased -0.32

What is InnovAge Holding Corp (INNV)'s business?

InnovAge Holding Corp. is a healthcare delivery platform. The Company is engaged in managing the care of high-cost, frail, and dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). Its programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its PACE program, it offers a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center, and third-party medical appointments and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who oversee all aspects of each participant’s care plan.

What is the price predicton of INNV Stock?

Wall Street analysts forecast INNV stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INNV is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is InnovAge Holding Corp (INNV)'s revenue for the last quarter?

InnovAge Holding Corp revenue for the last quarter amounts to 239.71M USD, increased 14.69

What is InnovAge Holding Corp (INNV)'s earnings per share (EPS) for the last quarter?

InnovAge Holding Corp. EPS for the last quarter amounts to 0.08 USD, decreased -180.00

How many employees does InnovAge Holding Corp (INNV). have?

InnovAge Holding Corp (INNV) has 2440 emplpoyees as of March 30 2026.

What is InnovAge Holding Corp (INNV) market cap?

Today INNV has the market capitalization of 1.07B USD.